Ultra-low doses of TX-004HR to improve symptoms of vulvar and vaginal atrophy (VVA) while maintaining serum levels of estradiol within the normal postmenopausal range Meeting Abstract


Authors: Goldfarb, S. B.; Carter, J.; Bernick, B.; Mirkin, S.
Abstract Title: Ultra-low doses of TX-004HR to improve symptoms of vulvar and vaginal atrophy (VVA) while maintaining serum levels of estradiol within the normal postmenopausal range
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 535s
Language: English
ACCESSION: WOS:000442916003439
DOI: 10.1200/JCO.2018.36.15_suppl.10074
PROVIDER: wos
Notes: Meeting Abstract: 10074 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jeanne Carter
    159 Carter
  2. Shari Goldfarb
    149 Goldfarb